Patterns of use of symptomatic treatments for Alzheimer's disease dementia (AD)

BMC Neurology

Table 2 First symptomatic AD treatment in newly diagnosed AD dementia patients from a major U.S. health plan and CPRD database

^a < 1% of patients using Donepezil as their first therapy used the 23mg/day dose
^bMonotherapy is defined as one anti-dementia drug and duration of therapy > 21 days. If monotherapy lasts < = 21 days, these patients were counted as trial/uncertain category (n = 76)

ISSN: 1471-2377